Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Cellular and Molecular Medicine"
DOI: 10.1111/jcmm.15319
Abstract: Duchenne muscular dystrophy is a severe muscle wasting disease caused by mutations in the dystrophin gene (dmd). Ataluren has been approved by the European Medicines Agency for treatment of Duchenne muscular dystrophy. Ataluren has been…
read more here.
Keywords:
effect;
effect ataluren;
premature stop;
stop codons ... See more keywords